We use cookies to improve your experience on our site. By using our site you consent to the use of cookies. Learn More
The Trinity Challenge on Antimicrobial Resistance has awarded four innovative solutions with funding Learn about our winners
16 February 2024
The Ineos Oxford Institute (IOI) has generously contributed to the Trinity Challenge’s ongoing efforts to support advocacy and campaign development on antibiotic resistance. The Trinity Challenge is currently running an innovation competition to identify and resource solutions to antibiotic resistance in low- and middle-income countries at the community level across the One Health spectrum. However, in the medium and longer term it is crucial to also strengthen the advocacy networks and develop clear messaging on antibiotic resistance.
Professor Marc Mendelson, Director, the Trinity Challenge, said: “We are extremely pleased to have been able to work with the Ineos Oxford Institute to increase our activity to push for the recognition of antibiotic resistance as a major global issue. The funding from the IOI will allow our team to make connections across the world, develop new approaches to communicating this complex issue, and build the foundation for stronger campaigning.
“In the Trinity Challenge’s spirit of collaboration, we need to find ways to engage with different groups such as young people in order to strengthen advocacy around antibiotic resistance and ultimately to help protect the power of antibiotics now and for future generations.”
Professor Tim Walsh, Director of Biology at the Ineos Oxford Institute for antimicrobial research, said: “Our planet is deeply interconnected economically, culturally, and socially. A global health challenge like antimicrobial resistance (AMR) is a collective responsibility across countries and sectors.
“Solutions to tackle AMR, need to be bold, innovative, and evidence-led. We are delighted to partner with the Trinity Challenge as they champion data driven solutions to mitigate this global crisis.
“Whilst AMR threatens the very foundation of modern society, public awareness of AMR is worryingly low. We look forward to working with the Trinity Challenge to increase engagement on the issue amongst patients, youth and other stakeholders.”
The Trinity Challenge has been awarded $500,000 from the Patrick J. McGovern Foundation to boost the recently launched Trinity Challenge on Antimicrobial Resistance, an innovation prize to find solutions to tackle antibiotic resistance in low- and middle-income countries.
Eighteen months since the awards were announced and the prizes distributed, where are they now?
Perceptions of the importance & effectiveness of the vaccines declined between June 2020 & January 2022.